Rubius Therapeutics OverviewRubius Therapeutics Net Income
Profitability analysis for RUBY.
Quarterly Net Income
-$41.28M
↑ 24.97% YoY
As of Dec 2022
Annual Net Income (TTM)
-$233.75M
↓ 18.93% YoY
Trailing 12 months ending Dec 2022
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...